1. Home
  2. AMLX vs RDW Comparison

AMLX vs RDW Comparison

Compare AMLX & RDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

BUY

Current Price

$27.71

Market Cap

3.8B

Sector

Health Care

ML Signal

BUY

Logo Redwire Corporation

RDW

Redwire Corporation

BUY

Current Price

$10.78

Market Cap

3.4B

Sector

Industrials

ML Signal

BUY

Company Overview

Basic Information
Metric
AMLX
RDW
Founded
2014
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.4B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
AMLX
RDW
Price
$27.71
$10.78
Analyst Decision
Strong Buy
Buy
Analyst Count
12
10
Target Price
★ $42.36
$14.69
AVG Volume (30 Days)
1.2M
★ 10.8M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 65.46
2.98
EPS
N/A
★ N/A
Revenue
★ $380,786,000.00
$335,381,000.00
Revenue This Year
N/A
$41.71
Revenue Next Year
N/A
$18.65
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 1612.94
10.29
52 Week Low
$10.83
$4.87
52 Week High
$41.14
$26.64

Technical Indicators

Market Signals
Indicator
AMLX
RDW
Relative Strength Index (RSI) 36.58 46.59
Support Level $12.97 $9.99
Resistance Level $34.35 $11.96
Average True Range (ATR) 1.39 0.61
MACD -0.74 -0.06
Stochastic Oscillator 9.33 28.42

Price Performance

Historical Comparison
AMLX
RDW

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

About RDW Redwire Corporation

Redwire Corp is an integrated space and defense technology company focused on technologies including aerospace infrastructure, autonomous systems and multi-domain operations, leveraging digital engineering and artificial intelligence automation. The Company develops and provides mission critical solutions based on space and defense technology platform offerings for government, commercial and civil customers through both short- and long-duration projects. These include technologies and production capability for next-generation spacecraft, large space infrastructure, microgravity capabilities, combat autonomous systems, optical sensors and radio frequency payloads that provide intelligence, surveillance, and reconnaissance capabilities for U.S. and allied nations across multiple domains.

Share on Social Networks: